The rapid and sustained effects of Tazbentetol on clinical outcome measures are consistent with findings from a NIH-supported, published Alzheimer's mouse model study where synapse loss in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback